Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Bronchodilator

From Wikipedia, the free encyclopedia
Drug which widens the lung airways
Medical intervention
Bronchodilator
SpecialtyPulmonology

Abronchodilator orbroncholytic[1] (although the latter occasionally includessecretory inhibition as well) is a substance that dilates thebronchi andbronchioles, decreasing resistance in therespiratory airway and increasing airflow to thelungs. Bronchodilators may beoriginating naturally within the body, or they may bemedications administered for the treatment of breathing difficulties, usually in the form ofinhalers. They are most useful inobstructive lung diseases, of whichasthma andchronic obstructive pulmonary disease are the most common conditions. They may be useful inbronchiolitis andbronchiectasis, although this remains somewhat controversial. They are often prescribed but of unproven significance inrestrictive lung diseases.[2]

Bronchodilators are either short-acting or long-acting. Short-acting medications provide quick or "rescue" relief from acutebronchoconstriction. Long-acting bronchodilators help to control and prevent symptoms. The three types of prescription bronchodilating drugs arebeta-2 adrenergic agonists (short- and long-acting),anticholinergics (short- and long-acting), andtheophylline (long-acting).

Short-acting β2-adrenergic agonists

[edit]

These are quick-relief or "rescue" medications that provide quick, temporary relief from asthma symptoms or flare-ups. These medications usually take effect within 20 minutes or less, and can last from four to six hours. These inhaled medications are best for treating sudden and severe or new asthma symptoms. Taken 15 to 20 minutes ahead of time, these medications can also prevent asthma symptoms triggered by exercise or exposure to cold air. Some short-acting β-agonists, such assalbutamol, are specific to the lungs; they are called β2-adrenergic agonists and can relieve bronchospasms without unwantedcardiac side effects of nonspecific β-agonists (for example,ephedrine orepinephrine). Patients who regularly or frequently need to take a short-acting β2-adrenergic agonist should consult their doctor, as such usage indicates uncontrolled asthma, and their routine medications may need adjustment.[citation needed]

Long-acting β2-adrenergic agonists

[edit]
Main article:Long-acting beta-adrenoceptor agonist

These are long-term medications taken routinely in order to control and prevent bronchoconstriction. They are not intended for fast relief. These medications may take longer to begin working, but relieve airway constriction for up to 12 hours.Commonly taken twice a day with an anti-inflammatory medication, they maintain open airways and prevent asthma symptoms, particularly at night.[citation needed]

Salmeterol andformoterol are examples of these.

Anticholinergics

[edit]
Main article:Anticholinergics

Some examples of anticholinergics aretiotropium (Spiriva) andipratropium bromide.[citation needed]

Tiotropium is a long-acting, 24-hour, anticholinergic bronchodilator used in the management ofchronic obstructive pulmonary disease (COPD).

Only available as an inhalant, ipratropium bromide is used in the treatment of asthma and COPD. As a short-acting anticholinergic, it improves lung function and reduces the risk of exacerbation in people with symptomatic asthma.[3] However, it will not stop an asthma attack already in progress. Because it has no effect on asthma symptoms when used alone, it is most often paired with a short-acting β2-adrenergic agonist. While it is considered a relief or rescue medication, it can take a full hour to begin working. For this reason, it plays a secondary role in acute asthma treatment. Dry throat is the most common side effect. If the medication gets in contact with the eyes, it may cause blurred vision for a brief time.

The use of anticholinergics in combination with short-acting β2-adrenergic agonists has been shown to reduce hospital admissions in children and adults with acute asthma exacerbations.[4][5]

Other

[edit]

Available in oral and injectable form,theophylline is a long-acting bronchodilator that prevents asthma episodes. It belongs to the chemical classmethylxanthines (along with caffeine). It is prescribed in severe cases of asthma or those that are difficult to control. It must be taken 1–4 times daily, and doses cannot be missed. Blood tests are required to monitor therapy and to indicate when dosage adjustment is necessary. Side effects can include nausea, vomiting, diarrhea, stomach or headache, rapid or irregular heart beat, muscle cramps, nervous or jittery feelings, and hyperactivity. These symptoms may signal the need for an adjustment in medication. It may promoteacid reflux, also known as GERD, by relaxing the lower esophageal sphincter muscle. Some medications, such as seizure and ulcer medications and antibiotics containingerythromycin, can interfere with the way theophylline works. Coffee, tea, colas, cigarette-smoking, and viral illnesses can all affect the action of theophylline and change its effectiveness. A physician should monitor dosage levels to meet each patient's profile and needs.

Additionally, somepsychostimulant drugs that have an amphetamine like mode of action, such asamphetamine,[6]methamphetamine, andcocaine,[7] have bronchodilating effects and were used often forasthma due to the lack of effective β2-adrenergic agonists for use as bronchodilator, but are now rarely, if ever, used medically for their bronchodilatory effects.

Gaseouscarbon dioxide also relaxes airway musculature:hypocapnia caused by deliberatehyperventilation increases respiratory resistance whilehypercapnia induced by carbon dioxide inhalation reduces it;[8] however, this bronchodilating effect of carbon dioxide inhalation only lasts 4 to 5 minutes.[9] Nonetheless, this observation has inspired the development ofS-1226, carbon dioxide-enriched air formulated withnebulizedperflubron.[10]

Common bronchodilators

[edit]

The bronchodilators are divided into short- and long-acting groups. Short-acting bronchodilators are used for relief of bronchoconstriction, while long-acting bronchodilators are predominantly used for prevention.

Short-acting bronchodilators include:

Long-acting bronchodilators include:

References

[edit]
  1. ^Venes, Donald (2017-01-25).Taber's Cyclopedic Medical Dictionary. F.A. Davis.ISBN 9780803659407.
  2. ^Sathe NA, Krishnaswami S, Andrews J, Ficzere C, McPheeters ML (July 2015)."Pharmacologic Agents That Promote Airway Clearance in Hospitalized Subjects: A Systematic Review"(PDF).Respiratory Care.60 (7):1061–70.doi:10.4187/respcare.04086.PMID 25944943.S2CID 7017557.
  3. ^Price D, Fromer L, Kaplan A, van der Molen T, Román-Rodríguez M (July 2014)."Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?".npj Primary Care Respiratory Medicine.24 (1) 14023.doi:10.1038/npjpcrm.2014.23.PMC 4373380.PMID 25030457.
  4. ^Rodrigo GJ, Castro-Rodriguez JA (September 2005)."Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis".Thorax.60 (9):740–6.doi:10.1136/thx.2005.040444.PMC 1747524.PMID 16055613.
  5. ^Griffiths B, Ducharme FM (December 2013). "Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children".Paediatric Respiratory Reviews.14 (4):234–5.doi:10.1016/j.prrv.2013.08.002.PMID 24070913.
  6. ^Amphetamine is listed as having medical uses as bronchodilator. Medic8
  7. ^Streatfeild D (17 June 2003).Cocaine: An Unauthorized Biography. Macmillan. p. 110.ISBN 978-0-312-42226-4. Retrieved14 February 2011.
  8. ^van den Elshout, F. J.; van Herwaarden, C. L.; Folgering, H. T. (January 1991)."Effects of hypercapnia and hypocapnia on respiratory resistance in normal and asthmatic subjects".Thorax.46 (1):28–32.doi:10.1136/thx.46.1.28.ISSN 0040-6376.PMC 1020910.PMID 1908137.
  9. ^Fisher, H. K.; Hansen, T. A. (November 1976)."Site of action of inhaled 6 per cent carbon dioxide in the lungs of asthmatic subjects before and after exercise".The American Review of Respiratory Disease.114 (5):861–870.doi:10.1164/arrd.1976.114.5.861 (inactive 11 July 2025).ISSN 0003-0805.PMID 984580.{{cite journal}}: CS1 maint: DOI inactive as of July 2025 (link)
  10. ^Green, Francis H. Y.; Leigh, Richard; Fadayomi, Morenike; Lalli, Gurkeet; Chiu, Andrea; Shrestha, Grishma; ElShahat, Sharif G.; Nelson, David Evan; El Mays, Tamer Y.; Pieron, Cora A.; Dennis, John H. (2016-07-28)."A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers".Trials.17 361.doi:10.1186/s13063-016-1489-8.ISSN 1745-6215.PMC 4964056.PMID 27464582.

External links

[edit]
Major chemical drug groups – based upon theAnatomical Therapeutic Chemical Classification System
gastrointestinal tract
/metabolism (A)
blood and blood
forming organs (B)
cardiovascular
system
(C)
skin (D)
genitourinary
system
(G)
endocrine
system
(H)
infections and
infestations (J,P,QI)
malignant disease
(L01–L02)
immune disease
(L03–L04)
muscles,bones,
andjoints (M)
brain and
nervous system (N)
respiratory
system
(R)
sensory organs (S)
otherATC (V)
Adrenergics,inhalants
Short-acting β2 agonists
Long-acting β2 agonists
Ultra-long-acting β2 agonists
Other
Glucocorticoids
Anticholinergics/
muscarinic antagonist
Mast cell stabilizers
Xanthines
Eicosanoid inhibition
Leukotriene antagonists
Arachidonate 5-lipoxygenase inhibitors
Thromboxane receptor antagonists
Non-xanthinePDE4 inhibitors
Others/unknown
Combination products
Respiration
Control
Lung volumes
Circulation
Interactions
Insufficiency
National
Other
Retrieved from "https://en.wikipedia.org/w/index.php?title=Bronchodilator&oldid=1300689701"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp